Sun Pharmaceuticals Q4 Results: Profit Falls 19%, Misses Estimates

What's Next for Sun Pharma After a 19% Profit Drop?

Sun Pharma reported a net profit of ₹2,154 crore, down from the same period last year Sun Pharmaceutical Industries Ltd., India’s largest drug manufacturer by revenue, reported a sharp 19% drop in net profit for the fourth quarter of the financial year 2025. The decline in profit, however, was not due to poor sales but mainly due to exceptional costs related to restructuring efforts in the U.S. and a write-down in one of its investments. Despite…

Sun Pharmaceuticals Q4 Results: Profit Falls 19%, Misses Estimates

Sun Pharmaceutical Industries Ltd.'s profit declined in the fourth quarter of fiscal year 2024-25, thereby missing the estimates shared by analysts.India’s largest drugmaker's consolidated net profit fell 19% year-on-year to Rs 2,154 crore in the March quarter, according to an exchange filing on Thursday. That compares with the Rs 2,794-crore consensus estimate of analysts tracked by Bloomberg.Sun Pharma Q4 FY25 Highlights (YoY) Revenue up 8% at…